Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19.

Sofia, Rosaria; Carbone, Mattias; Landoni, Giovanni; Zangrillo, Alberto; Dagna, Lorenzo

Sofia, Rosaria; Carbone, Mattias; Landoni, Giovanni; Zangrillo, Alberto; Dagna, Lorenzo.

Sofia R; Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Carbone M; Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Landoni G; Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: landoni.giovanni@hsr.it.
Zangrillo A; Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Dagna L; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Faculty of Medicine, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: dagna.lorenzo@unisr.it.

Eur J Intern Med ; 100: 21-24, 2022 06.

Article in English | MEDLINE | ID: covidwho-1783302

Subject(s)

COVID-19; Venous Thrombosis; Anticoagulants/therapeutic use; Humans; Lung; Secondary Prevention; Venous Thrombosis/prevention & control

Keywords

Anticoagulants; Antithrombotic therapy; COVID-19; MicroCLOTS; SARS-CoV-2; Thromboinflammatory syndrome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Venous Thrombosis / COVID-19 Limits: Humans Language: English Journal: Eur J Intern Med Journal subject: Internal Medicine Year: 2022 Document Type: Article Affiliation country: J.ejim.2022.04.009

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google